LOPINAVIR PHARMACOPOEIA européenne (EP) R

Code: Y0001498 D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Lopinavir may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations and plasma samples by chromatogra...


 En savoir plus

Votre prix
$198.16 EACH
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Lopinavir may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations and plasma samples by chromatography techniques.

Caution

Please find SDS provided by EDQM here..

General description

Lopinavir is an antiretroviral agent and a protease inhibitor indicated for the management of human immunodeficiency virus (HIV) infection. It is a key component of Kaletra, the co-formulation of lopinavir and ritonavir.

Other Notes

Sales restrictions may apply.

Packaging

Unit quantity: 170 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

agencyEP
application(s)pharmaceutical (small molecule)
biological sourcesynthetic
formatneat
gradepharmaceutical primary standard
InChI keyKJHKTHWMRKYKJE-SUGCFTRWSA-N
InChI1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
manufacturer/tradenameEDQM
packagingpkg of 170 mg
shipped inambient
storage conditionprotect from light
storage temp.2-8°C
Cas Number192725-17-0
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.